GT BIOPHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
GT BIOPHARMA, INC. (GTBP) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 57.55 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 57.55M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 57.55M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 50.53M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 49.46M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number as first filed |
|---|---|---|
| 2026-06-30 | 57.55M shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 57.55M shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 50.53M shares 10-Q · filed 2026-08-14 | |
| 2025-09-30 | 49.46M shares 10-Q/A · filed 2026-03-06 | |
| 2025-06-30 | 16.75M shares 10-Q/A · filed 2026-03-06 | |
| 2025-03-31 | 1.77M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 1.12M shares 10-Q/A · filed 2026-03-06 | |
| 2024-09-30 | 1.13M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 1.13M shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 304.96K shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 304.96K shares 10-K · filed 2026-03-02 | |
| 2023-09-30 | 9.15M shares 10-Q · filed 2023-11-01 | |
| 2023-06-30 | 9.15M shares 10-Q · filed 2023-08-07 | |
| 2023-03-31 | 12.05M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 77.91K shares 10-K · filed 2025-02-21 | 2.34M shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 2.34M shares 10-Q · filed 2022-10-31 | |
| 2022-06-30 | 2.34M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 2.34M shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 77.91K shares 10-K · filed 2024-03-26 | 2.34M shares 10-K · filed 2022-03-28 |
| 2021-03-31 | 5.32M shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 221.04K shares 10-K · filed 2023-03-30 | |
| 2020-09-30 | 7.83M shares 10-Q · filed 2020-11-13 | |
| 2020-06-30 | 6.83M shares 10-Q/A · filed 2020-08-18 | |
| 2020-03-31 | 1.81M shares 10-Q · filed 2020-05-15 | |
| 2019-12-31 | 106.65K shares 10-K · filed 2022-03-28 | 1.81M shares 10-K · filed 2020-03-27 |
| 2018-12-31 | 106.65K shares 10-K · filed 2021-04-16 | 1.81M shares 10-K · filed 2019-03-29 |
| 2017-12-31 | 0.00 shares 10-K · filed 2020-03-27 | |
| 2016-12-31 | 15.55K shares 10-K · filed 2019-03-29 | |
| 2015-12-31 | 41.75K shares 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |